Fresenius Medical Care AG (NYSE:FMS) Shares Purchased by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. boosted its position in shares of Fresenius Medical Care AG (NYSE:FMS) by 5.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,278 shares of the company’s stock after buying an additional 442 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Fresenius Medical Care were worth $210,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC grew its stake in Fresenius Medical Care by 8.4% in the 4th quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company’s stock valued at $129,000 after acquiring an additional 441 shares during the period. MML Investors Services LLC grew its position in shares of Fresenius Medical Care by 5.3% in the third quarter. MML Investors Services LLC now owns 15,019 shares of the company’s stock valued at $320,000 after purchasing an additional 753 shares during the period. Smartleaf Asset Management LLC grew its position in shares of Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock valued at $28,000 after purchasing an additional 806 shares during the period. DAVENPORT & Co LLC increased its stake in shares of Fresenius Medical Care by 1.5% during the fourth quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company’s stock worth $1,316,000 after purchasing an additional 862 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Fresenius Medical Care by 5.8% during the 4th quarter. Bank of New York Mellon Corp now owns 21,951 shares of the company’s stock worth $497,000 after purchasing an additional 1,205 shares during the last quarter. Hedge funds and other institutional investors own 8.37% of the company’s stock.

Analyst Ratings Changes

FMS has been the topic of several recent research reports. Truist Financial lifted their target price on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Bank of America upgraded shares of Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd. Finally, StockNews.com upgraded shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th.

Fresenius Medical Care Trading Down 1.4 %

Shares of FMS stock opened at $24.29 on Monday. The stock has a market capitalization of $14.25 billion, a P/E ratio of 20.07, a price-to-earnings-growth ratio of 0.76 and a beta of 0.99. Fresenius Medical Care AG has a fifty-two week low of $17.93 and a fifty-two week high of $25.25. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The company has a 50 day moving average price of $23.86 and a 200 day moving average price of $22.39.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.